John G Ullman & Associates Inc Johnson & Johnson Transaction History

John G Ullman & Associates Inc

$630 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 21, 2023	BUY	$154.35 - $166.11 $2,932 - $3,156	19 Added 0.83%	2,311 $382,000
Q1 2023 May 05, 2023	BUY	$151.05 - $180.26 $6,042 - $7,210	40 Added 1.78%	2,292 $355,000
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $136,170 - $152,821	850 Added 60.63%	2,252 $398,000
Q2 2022 Jul 27, 2022	BUY	$168.19 - $186.01 $33,638 - $37,202	200 Added 16.64%	1,402 $249,000
Q1 2022 Apr 29, 2022	SELL	$158.14 - $179.59 $60,409 - $68,603	-382 Reduced 24.12%	1,202 $213,000
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $220,796 - $244,982	-1,416 Reduced 47.2%	1,584 $271,000
Q3 2021 Nov 02, 2021	SELL	$161.5 - $179.47 $14 Million - $15.5 Million	-86,449 Reduced 96.65%	3,000 $484,000
Q2 2021 Jul 23, 2021	SELL	$159.48 - $171.07 $87,714 - $94,088	-550 Reduced 0.61%	89,449 $14.7 Million
Q1 2021 Apr 22, 2021	SELL	$153.07 - $170.48 $157,662 - $175,594	-1,030 Reduced 1.13%	89,999 $14.8 Million
Q4 2020 Feb 05, 2021	SELL	$137.11 - $157.38 $103,380 - $118,664	-754 Reduced 0.82%	91,029 $14.3 Million
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $88,860 - $97,374	-633 Reduced 0.68%	91,783 $13.7 Million
Q2 2020 Jul 29, 2020	SELL	$128.81 - $155.51 $34,521 - $41,676	-268 Reduced 0.29%	92,416 $13 Million
Q1 2020 Apr 14, 2020	SELL	$111.14 - $153.99 $31,563 - $43,733	-284 Reduced 0.31%	92,684 $12.2 Million
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $67,575 - $77,613	-530 Reduced 0.57%	92,968 $13.6 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $216,703 - $242,632	-1,707 Reduced 1.79%	93,498 $12.1 Million
Q2 2019 Aug 02, 2019	SELL	$131.15 - $144.24 $111,084 - $122,171	-847 Reduced 0.88%	95,205 $13.3 Million
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $40,104 - $44,593	-319 Reduced 0.33%	96,052 $13.4 Million
Q4 2018 Jan 29, 2019	SELL	$122.84 - $147.84 $519,121 - $624,771	-4,226 Reduced 4.2%	96,371 $12.4 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $9.25 Million - $10.9 Million	-76,112 Reduced 43.07%	100,597 $13.9 Million
Q2 2018 Jul 23, 2018	BUY	$119.4 - $131.76 $1.2 Million - $1.32 Million	10,055 Added 6.03%	176,709 $21.4 Million
Q1 2018 Apr 19, 2018	SELL	$125.1 - $148.14 $2.32 Million - $2.75 Million	-18,557 Reduced 10.02%	166,654 $21.4 Million
Q4 2017 Jan 31, 2018	SELL	$131.22 - $143.62 $263,752 - $288,676	-2,010 Reduced 1.07%	185,211 $25.9 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $24.2 Million - $25.3 Million	187,221	187,221 $24.3 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account